Literature DB >> 17300966

LNA derivatives of a kissing aptamer targeted to the trans-activating responsive RNA element of HIV-1.

Isabelle Lebars1, Tristan Richard, Carmelo Di Primo, Jean-Jacques Toulmé.   

Abstract

We previously identified an RNA aptamer targeted to the trans-activating responsive (TAR) element of the HIV-1 genome [F. Ducongé, J.J. Toulmé, In vitro selection identifies key determinants for loop--loop interactions: RNA aptamers selective for the TAR RNA element of HIV--1. RNA 5 (1999) 1605--1614]. This hairpin aptamer binds to its target through loop-loop interactions. We derived chemically modified R06 aptamers that show improved nuclease resistance and affinity for TAR. We review here the results obtained with chimeric aptamers containing locked nucleic acid (LNA) residues. Chimeras containing 2 to 4 LNA residues in an RNA or 2'-O-methyl,RNA context display binding properties of interest and compete with the viral protein Tat for binding to TAR. NMR studies have shown that these properties are modulated by the conformation of the loop-loop helix depending on the presence of LNA residues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17300966     DOI: 10.1016/j.bcmd.2006.11.008

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  13 in total

Review 1.  Non-natural nucleic acids for synthetic biology.

Authors:  Daniel H Appella
Journal:  Curr Opin Chem Biol       Date:  2009-10-29       Impact factor: 8.822

2.  Aptamers: problems, solutions and prospects.

Authors:  A V Lakhin; V Z Tarantul; L V Gening
Journal:  Acta Naturae       Date:  2013-10       Impact factor: 1.845

Review 3.  In vitro selection of BNA (LNA) aptamers.

Authors:  Masayasu Kuwahara; Satoshi Obika
Journal:  Artif DNA PNA XNA       Date:  2013 Apr-Jun

4.  Inhibition of HIV Replication by Cyclic and Hairpin PNAs Targeting the HIV-1 TAR RNA Loop.

Authors:  Gregory Upert; Audrey Di Giorgio; Alok Upadhyay; Dinesh Manvar; Nootan Pandey; Virendra N Pandey; Nadia Patino
Journal:  J Nucleic Acids       Date:  2012-09-17

Review 5.  Chimeric aptamers in cancer cell-targeted drug delivery.

Authors:  Jagat R Kanwar; Kislay Roy; Rupinder K Kanwar
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-09-28       Impact factor: 8.250

Review 6.  Aptamers as both drugs and drug-carriers.

Authors:  Md Ashrafuzzaman
Journal:  Biomed Res Int       Date:  2014-09-11       Impact factor: 3.411

Review 7.  Aptamers Selected for Recognizing Amyloid β-Protein-A Case for Cautious Optimism.

Authors:  Farid Rahimi
Journal:  Int J Mol Sci       Date:  2018-02-27       Impact factor: 5.923

Review 8.  Silencing viral microRNA as a novel antiviral therapy?

Authors:  Ugo Moens
Journal:  J Biomed Biotechnol       Date:  2009-05-28

9.  NMR structure of a kissing complex formed between the TAR RNA element of HIV-1 and a LNA-modified aptamer.

Authors:  Isabelle Lebars; Tristan Richard; Carmelo Di Primo; Jean-Jacques Toulmé
Journal:  Nucleic Acids Res       Date:  2007-09-03       Impact factor: 16.971

10.  G-rich VEGF aptamer with locked and unlocked nucleic acid modifications exhibits a unique G-quadruplex fold.

Authors:  Maja Marušič; Rakesh N Veedu; Jesper Wengel; Janez Plavec
Journal:  Nucleic Acids Res       Date:  2013-08-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.